ICAM-3 activators are specialized chemical agents that promote the activation or enhance the function of the protein ICAM-3, known scientifically as Intercellular Adhesion Molecule 3. This protein is part of the immunoglobulin superfamily and is predominantly found on the surfaces of leukocytes, where it plays a crucial role in immune system function. ICAM-3 is instrumental in mediating the adhesion of leukocytes to endothelial cells and facilitating their migration toward areas of inflammation or injury. It binds to counter-receptor molecules such as LFA-1 (leukocyte function-associated antigen-1), which is found on T cells and other leukocytes, enabling cell-cell interactions that are essential for the immune response.
Activators of ICAM-3 may operate through direct or indirect means. Direct activators can bind to ICAM-3 and stabilize the molecule in an active conformation, potentially increasing its affinity for LFA-1 or other counter-receptors. Such binding can enhance the adhesion properties of leukocytes, allowing researchers to study the effects of increased ICAM-3 activity on the immune response, including cell adhesion, signaling, and migration. Indirect activators may not bind to ICAM-3 itself but instead influence cellular mechanisms that lead to the upregulation of ICAM-3 expression or its activation state. This could involve the activation of signaling pathways that culminate in the increased surface expression of ICAM-3 or the promotion of post-translational modifications that are necessary for its optimal activity. For example, they might augment the synthesis of ICAM-3 by enhancing the transcription of the TUB gene or by stabilizing the mRNA to increase protein translation. Alternatively, they could modify the glycosylation status of ICAM-3, which is known to affect its ligand-binding capabilities and cell adhesion properties.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator. JNK, a member of the MAPK family, can phosphorylate proteins that interact with ICAM-3, enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC). Activated PKC can phosphorylate proteins that interact with ICAM-3, enhancing its functional activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a potent activator of the adenylyl cyclase/cAMP pathway. This pathway can activate PKA, which phosphorylates proteins that interact with ICAM-3, enhancing its functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific phosphodiesterase inhibitor that raises intracellular cAMP levels. Increased cAMP can activate PKA, which phosphorylates proteins that interact with ICAM-3, enhancing its functional activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that can activate PKA. Activated PKA can phosphorylate proteins that interact with ICAM-3, enhancing its functional activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase 4 inhibitor that raises intracellular cAMP levels. Increased cAMP can activate PKA, which phosphorylates proteins that interact with ICAM-3, enhancing its functional activity. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide is a selective PDE3 inhibitor that increases cAMP levels. Increased cAMP can activate PKA, which phosphorylates proteins that interact with ICAM-3, enhancing its functional activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Bucladesine is a cell-permeable cAMP analog that activates PKA. Activated PKA can phosphorylate proteins that interact with ICAM-3, enhancing its functional activity. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a PDE3 and PDE4 inhibitor that raises cAMP levels. Increased cAMP can activate PKA, which phosphorylates proteins that interact with ICAM-3, enhancing its functional activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine is a hormone and neurotransmitter that activates the cAMP/PKA pathway. This can activate PKA, which phosphorylates proteins that interact with ICAM-3, enhancing its functional activity. | ||||||